SUBSCRIBE
SUBSCRIBE
News   Business   Deals

EvoGenix To List On ASX In August; Will Open Its IPO Within A Week

October 19, 2005 | 
1 min read
Antibody therapeutics company EvoGenix will open its initial public offering within a week and list on the ASX in early to mid-August, with the aim of raising AUD$9 million.
IPO
MORE ON THIS TOPIC
Salary negotiation, pay raise discussion or wages and benefit agreement, business deal or merger and acquisition concept, business people handshake on pile of money banknote after finish agreement.
Obesity
Roche bets up to $2.3B in Hanmi pact for next-gen weight loss drug
August 24, 2026
 · 
2 min read
 · 
Tristan Manalac
Untie the knots - Troubleshooting - problem solving concept image.
Deals
Werewolf and Ambros to tie the knot in $150M rare disease deal
August 21, 2026
 · 
2 min read
 · 
Michael Gibney
Business competitive advantage of paper plane in new competitive, competitor individual pointing in different ways for new competitive advantage on 3D render. Advantage for new idea competition.
IPO
Scribe’s early-stage IPO standout defies biotech’s derisking trend
August 20, 2026
 · 
3 min read
 · 
Gabrielle Masson
Words IPO (Initial public offering) with the trading data on the background.
IPO
2026 IPO stock tracker: How newly public biotechs are performing
August 19, 2026
 · 
1 min read
 · 
Gabrielle Masson